Compound 44 enhanced the expression of C/EBP homologous protein (CHOP) in MIA PaCa-2 human pancreatic cancer cells, an effect consistent with that of its congener lathyrisol A [43]. This evidence concerns the gene DDIT3 and pancreatic neoplasm.